Revolution Medicines, Inc. Warrant (RVMDW) Stock Price
RVMDWStock
$11.98+5508.39%52W
Market Cap—
P/E—
PEG Ratio—
Div yield—
Beta4.82
RVMDW Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)604.83%
Price vs S&P 500 (4W)33.03%
VGM Score87.62
Industry Peers — Biological Products(183)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
RVMDWRevolution Medicines, Inc. Warrant | — | — | A | $11.98 |
| AMGNAmgen Inc | C | C | B | $442.24 |
| GILDGilead Sciences Inc | C | B | B | $148.77 |
| MRNAModerna, Inc. Common Stock | D | C | A | $158.83 |
| ARGXargenx SE American Depositary Shares | D | A | B | $1019.49 |
| RVMDRevolution Medicines, Inc. Common Stock | F | — | A | $211.38 |
| BIIBBiogen Inc. Common Stock | C | D | B | $220.77 |
| BNTXBioNTech SE American Depositary Share | C | C | B | $114.05 |
| NBIXNeurocrine Biosciences Inc | C | B | C | $153.37 |
| EXELExelixis Inc | C | B | B | $56.72 |
| HALOHalozyme Therapeutics, Inc. | C | B | A | $109.32 |
About Revolution Medicines, Inc. Warrant
Revolution Medicines is a clinical-stage precision oncology company developing targeted therapies for RAS-addicted cancers, a significant unmet need in oncology. Using proprietary structure-based drug discovery, the company creates small molecules that target unconventional binding sites on RAS variants. Its pipeline features RAS(ON) Inhibitors designed as monotherapy or combination treatments.